Accord Files Stelara Rival With EMA

Intas Unit Submits Application For Dong-A/Meiji Seika Pharma Ustekinumab Biosimilar

 
• By David Wallace
  
EMA
Intas’s Accord has filed ustekinumab with the EMA
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products